Validation, Commissioning & Design Featured Articles
-
The ROI Of Pharma MES: How Investing In cGMP Compliance Saves Money
10/9/2024
Transform your pharmaceutical manufacturing processes and enhance compliance by implementing a modern pharma manufacturing execution system (MES).
-
A Blueprint For Avoiding FDA Recalls
10/9/2024
Avoid FDA recalls and safeguard your life sciences business. Learn how QMS and EBR/eDHR solutions can prevent costly product recalls and ensure compliance with FDA regulations.
-
Elevate Your Life Sciences QMS: 5 Must-Have Features
10/8/2024
With advanced features and better visibility into operations, uncover how MasterControl helps organizations navigate the complexities of the life sciences industry.
-
ICH Guidelines: Challenges And Solutions For Pharma Manufacturers
10/8/2024
Take the next step in enhancing your pharmaceutical manufacturing processes by investing in a robust quality management system (QMS) designed for ICH compliance and operational excellence.
-
The Transformational Impact Of A Digital Backbone
10/4/2024
Relying on fragmented data becomes problematic when teams need to dissect cell line performance data and that data is not in a digital backbone.
-
Expert Voices: Why Aren't QC Labs Fully Automated Yet?
10/4/2024
Leading automation experts chime in on why QC labs, otherwise ideal for robotics, have been slow to adopt and standardize the technology.
-
Technology Transfer And The Need For Digital Transformation
10/4/2024
The right data management platform can streamline biopharma technology transfer by bridging digital gaps, accelerating commercialization, ensuring compliance, and reducing costs.
-
A Risk-Based Approach To Validation Studies For Sterilizing-Grade Filtration And Single-Use Systems
10/3/2024
One way to address risk related to product quality is by implementing a Question-Based Review approach. Read on to learn about this approach and its advantages.
-
What To Do When Your Regulatory Findings Need Quality Risk Management Action
10/2/2024
More than half of all recent warning letters issued by the FDA include citations for absent or incomplete risk assessments. This article examines what regulators are looking for.
-
How Digital Twins Are Redefining Biotech Production And Labor
10/1/2024
Digital Twins are revolutionizing biotechnology by optimizing production processes, enhancing quality control, and changing the workforce. They offer efficiency, predictive maintenance, and compliance benefits.